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In rodents and felines, intravitreal administration of adenosine triphosphate (ATP) has
been shown to induce photoreceptor death providing a tractable model of retinal
degeneration in these species. This study investigated the long term effects of
photoreceptor loss in an ATP induced feline model of retinal degeneration. Six normal
sighted felines were unilaterally blinded using intravitreal ATP injections and assessed
using electroretinography (ERG) and optical coherence tomography (OCT). At 30 h
(n = 3) or 12 weeks (n = 3) post-injection, the animals were euthanized and the
eyes enucleated. Retinae were sectioned and labeled using immunohistochemistry for
markers of cell death, neural remodeling and gliosis. Ongoing cell death and retinal
degeneration was observed in the outer retina at both 30 h and 12 weeks following
unilateral ATP injection. Markers of mid to late-stage retinal remodeling such as cell
displacement and aberrant neurite growth were observed in the inner retina at 12 weeks
post-injection. Ganglion cells appeared to remain intact in ATP injected eyes. Müller cell
gliosis was observed throughout the inner and outer retina, in some parts completely
enveloping and/or displacing the surviving neural tissue. Our data suggests that the
ATP injected feline retina continues to undergo progressive retinal degeneration and
exhibits abnormalities consistent with a description of retinal remodeling commonly seen
in other models of retinal degeneration. These findings validate the use of intravitreal
ATP injection in feline as a large animal model of retinal degeneration which may
aid in development of therapies aiming to restore visual function after photoreceptor
degeneration.
Keywords: retina, gliosis, animal models, adenosine triphosphate, retinal degeneration, feline, photoreceptor
cells, retinitis pigmentosa
INTRODUCTION
Retinitis pigmentosa (RP) is an inherited retinal dystrophy characterized by dysfunction and
progressive loss of rod and/or cone photoreceptors in the retina. In the advanced stages of
disease, the inner retina undergoes remodeling and cell death as a secondary reaction to the
initial disease etiology (Milam et al., 1998; Strettoi et al., 2002; Jones et al., 2003; Marc et al.,
2003; Sullivan et al., 2003; Kalloniatis and Fletcher, 2004). Understanding the mechanisms behind
the secondary inner retinal disease processes in these conditions is vital as we move towards
for the restoration of functional vision in patients with these conditions using retinal prostheses.
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Animal models of photoreceptor degeneration allow
researchers to explore the pathological processes involved
in these diseases. The need for safe, rapid and effective
large eyed animal models of retinal disease has intensified
as we move to an era of restorative strategies such as
neural prostheses, optogenetics and photoreceptor sheet
transplantation (Dahlmann-Noor et al., 2010; O’Brien
et al., 2012; Seiler and Aramant, 2012; Shepherd et al.,
2013; Singh et al., 2013; Zrenner, 2013) as well as stem
cell and gene replacement therapies (Limb and Daniels,
2008; Dahlmann-Noor et al., 2010). Large-eyed animal
models of blindness such as the P347L rabbit and the
P23H pig models of retinal degeneration (Jones et al., 2011;
Sommer et al., 2011) allow for proof of concept trials and
the assessment of efficacy for these strategies before they
are translated into the human. In order to maximize the
potential for restoration of vision in disease of photoreceptors,
a large animal model must recapitulate the degenerative
process observed in humans, including and importantly the
inner retinal neurons, especially the ganglion cells, which
must remain intact and capable of passing information to
higher centers. Even after successful clinical application
of a new technology, animal models remain relevant as
they enable researchers to better understand the impact of
primary and secondary degenerative processes on optimal
device or treatment performance (Bertschinger et al.,
2008).
We previously developed a feline model of retinal
degeneration using unilateral adenosine triphosphate (ATP)
injection, which lead to rapid photoreceptor cell death
followed by progressive degeneration over a 12 week period
(Aplin et al., 2014). However, the remodeling events in the
ATP-injected feline, have not yet been characterized. We
define retinal remodeling as degenerative changes occurring
secondary to a primary retinal insult that conform to the
description of remodeling events as originally described
by Jones et al. (2003, 2005) and Marc et al. (2003) seen
commonly throughout retinal degenerations. Whilst a
thorough characterization of retinal remodeling has been
described in ATP injected rat (Puthussery and Fletcher,
2009; Vessey et al., 2014), it is important to understand
the remodeling processes involved in the ATP-injected
feline model of retinal degeneration as there may be species
specific differences that are important when using the
models for research into vision restorative therapies. The
feline eye is larger, contains a higher cone photoreceptor
density compared to the rat and has an area of central
higher acuity vision (area centralis) which may affect the
profile of degeneration (Steinberg et al., 1973). Furthermore,
ATP-induced phototoxicity is thought to be mediated by
purinergic receptors, especially the receptor P2X7, and there
may be differences in retinal purine expression between
species (Puthussery and Fletcher, 2009; Vessey et al., 2012).
We therefore aimed to histologically characterize the extent
of retinal remodeling and degenerative processes in a
chronic, unilateral, ATP-induced feline model of retinal
degeneration.
MATERIALS AND METHODS
Anesthesia and Intraocular Injection
of ATP
Normally sighted adult laboratory felines (n = 6) were used in
this study. Three animals were a subset of a larger cohort used at
the completion of a previous study (Aplin et al., 2014). Treatment
of animals complied with the Association for Research in Vision
andOphthalmology Statement for Use of Animals inOphthalmic
and Vision Research, and the National Health and Medical
Research Council’s (NHMRC) ‘‘Australian Code of Practice for
the Care and Use of Animals for Scientific Purposes’’ (2013)
and the ‘‘Prevention of Cruelty to Animals Act’’ (1986; and
amendments). The study was approved by the Royal Victorian
Eye and Ear Hospital Animal Ethics Committee (RVEEH AEC;
#12/256AB).
Unilateral retinal degeneration was induced in the animals
using an intravitreal injection of ATP. This procedure has
been described at length elsewhere (Puthussery and Fletcher,
2009; Aplin et al., 2014; Vessey et al., 2014). In brief,
Animals were anesthetized with a subcutaneous injection of
ketamine (20 mg/kg, Ilium Ketamil, Troy Laboratories, NSW,
Australia) and xylazine (2 mg/kg, Ilium Xylazil-20, Troy
Laboratories, NSW, Australia) and a 100 µL solution of
sterile phosphate buffered saline (PBS, 0.9%) containing 0.2M
adenosine tri-phosphate hydrate (Sigma Pharmaceuticals, VIC,
Australia) and 0.2mg dexamethasone (4mg/ml, Dexamethasone,
Aspen Australia, NSW, Australia) was injected into one eye. The
fellow eye received a sham injection of 0.2 mg dexamethasone in
100 µL PBS as a control.
Structural and Functional Assessments
Twin-flash electroretinography (ERG) and optical coherence
tomography (OCT) were used to assess the effect of
ATP injection on retinal structure and function pre-
operatively and at 12 weeks post-injection. All assessment
and analysis methodologies performed on these animals
have been described in previous studies (Aplin et al.,
2014). In short, the integrity of the surviving retinal
structure was assessed with OCT scans across the area
centralis (Spectralis; HRA + OCT, Heidelberg Engineering,
Heidelberg, Germany) and quantified using a custom script
in ImageJ (version 1.481, provided in the public domain
by the National Institutes of Health, Bethesda, MD, USA).
Visual function was assessed using full field, twin-flash
ERG (Espion; Diagnosys LLC, Lowell, MA, USA) which
allowed for a separation of rod- and cone-pathway mediated
function.
Tissue Collection and Histology
At 30 h (n = 3) or 12 weeks (n = 3) after ATP injection,
animals were anesthetized using ketamine (20 mg/kg) and
xylazine (2 mg/kg) and then euthanized with an overdose
of sodium pentobarbitone (150 mg/kg, Troy Laboratories,
1http://imagej.nih.gov/ij/
Frontiers in Neuroanatomy | www.frontiersin.org 2 April 2016 | Volume 10 | Article 46
Aplin et al. Retinal Changes in a Model of Retinal Degeneration
intracardiac, NSW, Australia). Both eyes were enucleated
and the eye anterior to the ciliary body removed. The
remaining eyecups were fixed in 4% paraformaldehyde
for 30 min and washed in phosphate buffered solution
(PB, 0.9%). Sections were equilibrated in graded sucrose
solutions (10%, 20%, 30% w/v in PB) for 30 min each and
stored overnight. The control and ATP-injected retinae were
embedded in optimal cutting temperature compound (Tissue-
Tek, CA, USA), frozen with liquid nitrogen and cut into
serial sections at 12 µM on a cryostat (Microm, Walldorf,
Germany). Sections were collected on Poly-L-lysine coated
slides (Menzel-Glaser, Braunschweig, Germany) and stored
at−20◦C.
Cell death was measured using a commercially available
fluorometric terminal dUTP nick-end labeling (TUNEL) kit
as per Manufacturer’s instructions (DeadEnd Fluorometric
TUNEL system, TB235; Promega, Madison, WI, USA).
Fluorescence immunohistochemistry was used to assess retinal
cell survival, morphology and markers of retinal remodeling
near the area centralis. Immunohistochemical techniques
followed methodology previously described in ATP injected
rat and feline (Aplin et al., 2014; Vessey et al., 2014). After
sectioning, slides were defrosted and washed in PB for 10 min.
Sections were incubated at room temperature overnight in
primary antibody (detailed below) diluted in antibody buffer
(3% normal goat serum (NGS), 1% bovine serum albumin
(BSA), 0.5% Triton-X in PB). Primary antibody solution was
removed with PB washes and the sections incubated at room
temperature for 3 h in antibody buffer containing secondary
antibody diluted 1:500 (goat anti-mouse AlexaFluor 488, goat
anti-rabbit AlexaFluor 594, or goat anti-guinea pig Alexa-
Fluor 643; Life Sciences, VIC, Australia) and a nuclear stain
diluted 1:300 (40, 6-diamidino-2-phenylin-dole (DAPI); Life
Sciences, VIC, Australia). Finally sections were rinsed in PB
and coverslipped with a Mowiol-based antifade mounting
medium (Polysciences, Inc., PA, USA). Photomicrographs were
taken on a LSM 5 Meta laser scanning confocal microscope
(Carl Zeiss AG, Gottingen, Germany) with a 20× air or
40× oil objective. A linear contrast stretch was applied post-
acquisition in all images to enhance contrast. A minimum
of four images were taken for each vertical section, and
three sections were imaged per eye. Of these 36 sections, two
were chosen for display: one to best represent the average
level of degeneration across all images and the other to best
represent the more acutely affected regions of the degenerated
retina.
Primary antibodies were selected to examine possible
remodeling events at 12 weeks post ATP injection in both
the inner and outer retina. In order to examine photoreceptor
survival and remodeling we labeled rod photoreceptor outer
segments with mouse Rho 4D2 (R4D2; 1:50; Abcam, CA, USA;
Fariss et al., 1997), cone photoreceptor outer segments with
red/green and blue rabbit cone opsin (1:500; Millipore, VIC,
Australia; Linberg et al., 2001) and the cone photoreceptor
inner and outer segments with fluorescent labeled peanut
agglutinin (PNA; 1:200; Vector Laboratories, CA, USA; Linberg
et al., 2001). In order to examine synaptic and bipolar
cell changes in the rod pathway we labeled retinae with
mouse C-terminal-binding protein 2 (RIBEYE; 1:1000; BD
Biosciences, NSW, AUS) or rabbit anti-Protein Kinase Cα
(PKCα; 1:500; Sigma-Aldrich, NSW, Australia) and guinea
pig anti-Vesicular Glutamate Transporter (VGLUT1; 1:1000;
Millipore, VIC, Australia). PKCα is a label for rod bipolar
cells (Greferath et al., 1990; Lewis et al., 1998). RIBEYE
labels ribbon synapses in the inner and outer plexiform layers
(IPL/OPL), and some inner retinal cell bodies (Fisher et al.,
2005; Lewis et al., 2005). VGLUT1 labels glutamatergic synaptic
terminals (Fyk-Kolodziej et al., 2004). In order to examine
the effect of ATP-induced retinal degeneration on amacrine
and horizontal cells we labeled retinae with mouse Calbindin
(1:500; Swant, Bellinzona, Switzerland) and VGLUT1 (1:1000;
Millipore, VIC, Australia) or mouse Calretinin (1:500; Swant,
Bellinzona, Switzerland) and VGLUT1 (1:1000; Millipore, VIC,
Australia). Calbindin primarily labels horizontal cells and also
some ganglion cells and amacrine cells (Pasteels et al., 1990;
Lewis et al., 1998). Calretinin primarily labels amacrine cells and
some ganglion cells (Pasteels et al., 1990; Macneil et al., 2009).
Ganglion cells were labeled with anti-RNA-binding protein
with multiple splicing (RBPMS). RBPMS is a reliable label of
retinal ganglion cell bodies in mouse, rat, guinea pig, rabbit
and monkey retina (Rodriguez et al., 2014). A preliminary
analysis confirmed an identical pattern of labeling in the
feline.
Müller cell and astrocyte morphology was labeled using
rabbit antiglial fibrillary acid protein (GFAP; 1:10,000; Dako,
CA, USA) and mouse anti-Glutamine synthetase (GS; 1:1000;
Millipore, VIC, Australia). GFAP labels astrocytes and gliotic
Müller cells in the retina (Lewis et al., 1988; Vessey et al.,
2011; Vessey and Fletcher, 2012). GS labels normal functioning
or gliotic Müller cells with GS expression (Lewis et al., 1988)
To examine the effect of ATP-induced retinal degeneration
on microglia we labeled retinae with rabbit polyclonal anti-
ionized calcium-binding adaptor molecule 1 (IBA-1; 1:1000;
Wako Pure Chemical Industries, VA, USA). IBA-1 exclusively
labels microglia in the feline central nervous system and retina
(Ahmed et al., 2007; Zhang et al., 2011). The number of
photoreceptor nuclei in the outer nuclear layer (ONL), the
thickness of the ONL and RBMPS-labeled retinal ganglion
cell counts were quantified per 100 µm of retina across
the area centralis manually using ImageJ. Photoreceptor
nuclei density was calculated by multiplying the cell count
in each 100 µm bin by the total area of the ONL in
that bin.
Statistical Analysis
Analyses were performed on ERG amplitudes, OCT
measurements of retinal thicknesses, ONL thickness and
photoreceptor nuclei density using Statistical Software
(Graphpad Prism v.4, Graphpad Software, CA, USA; SigmaPlot
v12.5, Systat Software, CA, USA). ERG, OCT and histological
quantifications were analyzed using a non-parametric Wilcoxon
signed rank test (Wilcoxon), compared to the baseline for OCT
and ERG measurements and to the fellow sham injected eye
for histological quantification. The in-text results and all graph
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error bars represent one standard deviation from the mean (SD).
Results were considered significant when p< 0.05.
RESULTS
ATP Induced Retinal Degeneration Causes
Cell Death and Reorganization of the Outer
Retina
We first examined the level of functional and structural
loss present in this cohort of animals at 12 weeks post
ATP injection using OCT and ERG analysis. This data
is a subset of a larger population used in the previous
study (Aplin et al., 2014). At 12 weeks post ATP injection,
there was a significant reduction in average rod and cone
a-wave amplitudes compared to the pre-injection baseline
values (rod a-wave reduction = 84.97% ± 11.45%; Wilcoxon;
p< 0.001; cone a-wave reduction = 75.85%± 16.15%;Wilcoxon;
p < 0.023; n = 3 animals). There was no measurable
reduction in a-wave amplitudes in the sham-injected control
eyes. There was also a significant reduction in total retinal
thickness and ONL thickness at 12 weeks post ATP injection
compared to baseline in all animals (total retinal thickness
reduction = 34.69% ± 15.76%; Wilcoxon; p = 0.036; ONL
thickness reduction = 75.20% ± 13.11%; Wilcoxon; p < 0.001;
n = 3 animals). There was no measurable reduction in retinal
thicknesses in the sham injected eyes compared to baseline.
Given the ongoing loss of ERG waveform reported previously
in the ATP-injected feline, we sought to determine whether
retinal cell death was still occurring 12 weeks post ATP injection
in these animals and how this compared to acute cell death
only 30 h post-injection in an identical injection concentration.
Figure 1 shows representative vertical sections of feline retinae
in a control (Figure 1A), at 30 h (Figure 1B) and at 12 weeks
(Figure 1C) post ATP injection, labeled for cell nuclei (DAPI;
blue) and for cell death (TUNEL; green). Many TUNEL positive
cells can be seen in the 30 h condition, showing an acute
loss of photoreceptors in response to ATP injection (white
arrows). There were still some TUNEL positive nuclei 12 weeks
post-injection (white arrow); however, TUNEL positive cells
were qualitatively fewer in number than in the 30 h condition.
This suggests that the majority of photoreceptor loss occurs
as an acute response to ATP injection, but that progressive
photoreceptor cell death may continue to occur up to 12 weeks
after the initial insult.
The presence of photoreceptor nuclei alone does not
indicate that residual photoreceptors remain capable of
phototransduction. To better explore the overall integrity
of the surviving photoreceptors we examined markers for
photoreceptor opsins and outer segments across the area
centralis. Figures 2A–D shows representative vertical sections
of feline retinae labeled for cell nuclei (DAPI; blue), Rhodopsin
(R4D2; pink), Cone opsins (Cone opsin; red) and cone outer
segments (PNA; green) in a control (Figure 2A) and at a
higher magnification in 12 week (Figures 2B,C) ATP injected
eyes. White arrows indicate abnormal rhodopsin and cone
opsin expression located in the photoreceptor cell bodies.
Figure 2D shows a representative tile scan vertical section
of feline retinae across the area centralis at 12 weeks post
injection, labeled for photoreceptor opsins and outer segments
as above. By 12 weeks the outer retina had become highly
disorganized, with a few relatively normal areas interspersed
between areas of little to no normal outer segment survival. In
the worst affected areas, photoreceptor opsin was either absent
or primarily expressed in cell bodies, with some evidence of
abnormal cell displacement to other retinal layers (Figure 2C,
white arrow). In order to examine variations in photoreceptor
loss across the area centralis in the ATP-injected eyes we
then quantified ONL thickness (Figure 2E) and density of
photoreceptor nuclei (Figure 2F) in 100 µm sections across
the retina. There was a significant reduction in the thickness
of ATP-injected retinae compared to the same region in fellow
FIGURE 1 | ATP injection leads to secondary progressive loss of photoreceptors. (A–C) Representative sections of control and ATP-injected retinae labeled
for cell death (TUNEL; green) and cell nuclei (DAPI; blue) in a control (A), 30 h after injection (B) and 12 weeks after intravitreal injection with ATP (C). White arrows
indicate a TUNEL positive nuclei. ONL, outer nuclear layer; OPL, outer plexiform layer; INL, inner nuclear layer; IPL, inner plexiform layer; GCL, ganglion cell layer.
Scale bars = 100 µM.
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eye controls (Sham injected mean = 60.83 µm ± 2.871; ATP
injected mean = 28.89 µm ± 12.53; Mean reduction = 52.51%
± 18.48; Wilcoxon; p = 0.042; n = 3 animals). Density was
also significantly reduced compared to fellow eye controls
(Sham injected mean = 1117 cells/100 µm2 ± 35.37; ATP
injected mean = 257 cells/100 µm2 ± 44.79; Mean reduction
= 77.10% ± 6.403; Wilcoxon; p < 0.001; n = 3 animals). The
average thickness of the ONL in ATP injected eyes varied
considerably across the measured area (Figure 2E). In contrast,
photoreceptor density remained uniformly low even in thicker
areas (Figure 2F).
ATP Induced Retinal Degeneration
Remodels the Inner Retina by 12 Weeks
Post Injection
Given that severe loss and remodeling of the ONL would be
expected to lead to remodeling of inner retinal processes, we
examined the effect of ATP-induced chronic photoreceptor
degeneration on bipolar cells and synapses in the inner nuclear
layer (INL) and OPL/IPL. Figures 3A–C shows representative
vertical sections of feline retinae labeled for cell nuclei (DAPI;
blue) and ribbon synapses/inner retinal nuclei (RIBEYE; red)
in a control (Figure 3A) and two ATP injected eyes at
12 weeks post injection (Figures 3B,C). Figures 3D–F shows
representative vertical sections of feline retinae labeled for cell
nuclei (DAPI; blue), synaptic terminals (VGLUT1; red) and rod
bipolar cells (PKCα; green) in a control (Figure 3D) and two
ATP injected eyes at 12 weeks post injections (Figures 3E,F).
White arrows in all images show evidence for displaced synaptic
terminal expression or displacement of INL neuronal processes.
Asterisk in Figure 3B indicates a column of substantial inner
retinal neuronal displacement into the ONL. Sections for ATP
injected eyes were chosen in order to represent both the
average level of degeneration (Figures 3B,E) and the full extent
of degeneration across the retina (Figures 3C,F). We found
that RIBEYE consistently labeled a population of inner retinal
neuron somas in the cat, as has been previously reported
(Fisher et al., 2005). This labeling revealed the movement of
inner retinal neurons into the outer retina towards the RPE
(Figure 3B). Bipolar cells in the INL were still present even
in severely degenerated areas, although there was evidence of
late stage remodeling as evidenced by the displaced cell bodies,
synaptic terminals and cell processes. The integrity of the OPL
appeared highly compromised, with little to no VGLUT or
RIBEYE expression in degenerated areas and displaced punctate
labeling of VGLUT and RIBEYE extending as far as the
RPE.
Further to this, we then examined the effect of ATP induced
photoreceptor degeneration on horizontal cell, amacrine
cell and ganglion cell morphology. Figures 4A–C shows
representative vertical sections of feline retinae labeled for
cell nuclei (DAPI; blue), synaptic terminals (VGLUT1; red)
and amacrine, ganglion cell and horizontal cells (Calretinin;
green) in a control (Figure 4A) and two ATP injected eyes
at 12 weeks post injection (Figures 4B,C). Figures 4D–F
shows representative vertical sections of feline retinae labeled
for cell nuclei (DAPI; blue), synaptic terminals (VGLUT1;
red) and a different subset of amacrine, ganglion cell and
horizontal cells (Calbindin; green) in a control (Figure 4D)
and two ATP injected eyes at 12 weeks post injection
(Figures 4E,F). Figures 4G–I shows representative vertical
sections of feline retinae labeled for cell nuclei (DAPI;
blue) and ganglion cell bodies (RBPMS; green) in a control
(Figure 4G) and at 12 weeks post injection (Figures 4H,I).
White arrows in all images show evidence for abnormal
neurite outgrowth into the outer retina. Sections were
chosen in order to represent the both the average level
of degeneration (Figures 4B,E,H) and the full extent of
degeneration across the retina (Figures 4C,F,I). Amacrine
cell populations appeared to remain relatively well conserved
in ATP injected eyes, although amacrine and/or horizontal
cell processes could be seen to form remodeled neurite
bundles in the outer retina. The IPL was disorganized with
a reduction in the expression of synaptic terminals. There
was no significant reduction in ganglion cell count compared
to controls (control = 16.56 ± 5.232 cells/100 µm; ATP
injected = 12.52 ± 5.668 cells/100 µm; Wilcoxon; p = 0.430;
n = 3 animals). The ganglion cell layer (GCL) appeared
mostly intact 12 weeks post-injection of ATP, although
qualitatively there was clearly some cell loss in the worst
affected areas, as well as ganglion cell displacement into the IPL
(Figure 4I).
ATP Induced Retinal Degeneration Causes
Pathological Changes in Non-neural
Retinal Tissue
Another important facet of retinal degenerations are the
morphological changes in the glial components of the retina.
Figures 5A,B shows representative vertical sections of feline
retina labeled for cell nuclei (DAPI; blue), astrocytes and/or
gliotic Müller cells (GFAP; red) and normal functioning Müller
cells (GS; green) in a control (Figure 5A) and an ATP injected
eye at 12 weeks post injection (Figure 5B). Figure 5C shows
representative sections of retina 12 weeks after ATP injection
labeled for DAPI (blue) and GFAP (red) only, to better
display specific gliotic remodeling events. Figures 5D–F shows
representative sections of retina labeled for cell nuclei (DAPI;
blue) and microglia (IBA-1; red) in a control (Figure 5D)
and 12 weeks post injection (Figures 5E,F). The white arrow
in Figure 5C indicates the location of a glial column that
has displaced normal retinal layers. It was evident that Müller
cells in the retina had undergone severe gliosis in response to
ATP-induced retinal degeneration. In many parts of the retina,
gliotic Müller cells had completely entombed the outer retina
via the formation of a glial scar, at times with a thickness
comparable to the total surviving neural retina (Figures 5B,C).
Occasionally, glial columns infiltrated across all retinal layers,
creating areas devoid of neural tissue (Figure 5C). Microglial
activity was increased in ATP-injected eyes at 12 weeks post
injection (Figures 5E,F), especially in the inner retina but
also within the outer retina in more degenerated regions
(Figure 5F).
.
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FIGURE 2 | Surviving rod and cone photoreceptors undergo regionally variable degeneration. (A–D) Representative sections of control (A) and
ATP-injected retinae at 12 weeks post injection (B,C) labeled for rhodopsin (R4D2; pink) cone opsins (cone opsin; red), cone outer segments (PNA; green) and cell
nuclei (DAPI; blue). (D) Representative tile scan of ATP injected retinae at 12 weeks post injection labeled for rhodopsin (R4D2; pink) cone opsins (cone opsin; red),
cone outer segments (PNA; green) and cell nuclei (DAPI; blue). White arrows indicate abnormal rhodopsin and cone opsin expression. (E,F) Average ONL thickness
(E) and density (F) as a function of distance from the center of the area centralis in control and ATP injected eyes. The gray area corresponds to one standard
deviation (SD) from the mean in the ATP injected eyes, while the dotted line corresponds to one SD from the mean in control eyes. ONL, outer nuclear layer; OPL,
outer plexiform layer; INL, inner nuclear layer; IPL, inner plexiform layer; GCL, ganglion cell layer. Scale bars = 100 µM.
DISCUSSION
This study characterized long term changes in retinal
morphology induced by intravitreal ATP injection in a feline
model of retinal degeneration. Photoreceptor loss was associated
with abnormalities in the inner and outer neural retina
and widespread Müller cell gliosis. The markers for retinal
remodeling described in our study are consistent with findings
in the ATP injected rat (Vessey et al., 2014) and other models
of photoreceptor degeneration (Jones et al., 2005; Marc et al.,
2008). Our data suggest that ATP-induced retinal degeneration
in the feline follows a similar progression of late-stage retinal
remodeling to other models of photoreceptor degeneration,
albeit at a much more rapid rate compared to inherited retinal
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FIGURE 3 | Rod bipolar cells and synapses show evidence of retinal remodeling at 12 weeks after ATP injection. (A–C) Representative sections of control
(A) and ATP-injected retinae at 12 weeks post injection (B,C) labeled for ribbon synapses and inner retinal cell bodies (RIBEYE; red) and cell nuclei (DAPI; blue).
(D–F) Representative sections of control (D) and ATP-injected retinae at 12 weeks post injection (E,F) labeled for glutamatergic synapses (VGLUT1; red), rod bipolar
cells (PKCα; green), and cell nuclei (DAPI; blue). Vertical white arrows indicate displaced synapses. The horizontal arrow in (F) indicates a displaced cell process. The
asterisk indicates a column of displaced inner retinal neurons migrating into the ONL. ONL, outer nuclear layer; OPL, outer plexiform layer; INL, inner nuclear layer;
IPL, inner plexiform layer; GCL, ganglion cell layer. Scale bars = 100 µM.
degeneration in the feline (Narfström, 1985; Narfström and
Nilsson, 1987).
ATP Injection Causes Ongoing
Photoreceptor Degeneration
Photoreceptor cell death occurred acutely at 30 h post injection,
with evidence of slower photoreceptor death continuing out
to 12 weeks post injection. ATP is normally hydrolyzed
rapidly into adenosine within hours of entering the body
(Zhang et al., 2006; Köles et al., 2011), so the mechanism
by which photoreceptor cells continue to die at 12 weeks
cannot be a direct effect of the ATP injection. Chronic
photoreceptor degeneration may thus indicate a secondary
photoreceptor loss in these animals, possibly by mechanisms
independent from the initial disease etiology. Secondary cell loss
is common to photoreceptor degenerations but does not yet
have a complete explanation in the literature (Strettoi et al.,
2002; Jones et al., 2003, 2005; Marc et al., 2003; Fletcher,
2010).
The inner and outer segments did not consistently express rod
or cone opsins by 12 weeks after ATP injection. Instead, cone
and especially rhodopsin expression appeared to have primarily
migrated into the cell body of the photoreceptors. A similar
pattern of opsin expression has been reported in other models of
retinal degeneration (Gao et al., 2002; Fletcher et al., 2011) and is
likely to indicate photoreceptor stress and dysfunction, and may
directly contribute to ongoing photoreceptor cell death (Alfinito
and Townes-Anderson, 2002). We had previously reported a
smaller reduction in ONL thickness using OCT compared to
ERG a-wave amplitude loss (Aplin et al., 2014). Our currents
results imply that this may be due to survival of non-functional
photoreceptor cell bodies which contribute to the appearance of
a thicker ONL but do not contribute to light—evoked responses
using ERG. Furthermore, although the thickness of the ONL
varied considerably between animals and across the retina in
ATP injected animals, the density of photoreceptor nuclei was
uniformly low across the retina. Our results suggest that, at
least in rapid-acting models of photoreceptor degeneration, it
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FIGURE 4 | Amacrine and ganglion cells show evidence of retinal remodeling at 12 weeks after ATP injection. (A–C) Representative sections of control
(A) and ATP-injected retinae at 12 weeks post injection (B,C) labeled for glutamatergic synapses (VGLUT1; red), a subset of horizontal, amacrine and ganglion cells
(calretinin; green), and cell nuclei (DAPI; blue). (D–F) Representative sections of control (D) and ATP-injected retinae at 12 weeks post injection (E,F) labeled for
glutamatergic synapses (VGLUT1; red), a subset of horizontal, amacrine and ganglion cells (calbindin; green), and cell nuclei (DAPI; blue). (G–I) Representative
sections of control (G) and ATP-injected retinae at 12 weeks post injection (H,I) labeled for retinal ganglion cells (RBPMS; red) and cell nuclei (DAPI; blue). White
arrows indicate evidence of aberrant neurite bundle formation in the outer retina. ONL, outer nuclear layer; OPL, outer plexiform layer; INL, inner nuclear layer; IPL,
inner plexiform layer; GCL, ganglion cell layer. Scale bars = 100 µM.
is not possible to assess retinal survival by solely quantifying
the thickness of the ONL, as this may give an over-inflated
estimation of the number of functional photoreceptors still
present within the retina. As ONL thickness was seen to reduce
over time in our previous study (Aplin et al., 2014), we might
expect if this model was taken out to longer time points these
dysfunctional photoreceptors would be gradually cleared and the
thickness of the ONL would better correlate to residual ERG
a-wave amplitude as it does in some human retinal degenerations
(Cideciyan et al., 2008). A study of Leber’s Congenital Amaurosis
in human patients showed regions of thickened retina at the
beginning stages of the disease progression in some patients
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FIGURE 5 | Müller cells and microglia alter their expression in response to ATP injection. (A–C) Representative sections of control (A) and ATP-injected
retinae at 12 weeks post injection (B,C) labeled for astrocytes and gliotic Müller cells (GFAP; red), Müller cells (GS; green; A,B only), and cell nuclei (DAPI; blue).
(D–F) Representative sections of control (D) and ATP-injected retinae at 12 weeks post injection (E,F) labeled for microglia (IBA-1; red) and cell nuclei (DAPI; blue).
White arrow indicates location of a glial column extending throughout the retina. ONL, outer nuclear layer; OPL, outer plexiform layer; INL, inner nuclear layer; IPL,
inner plexiform layer; GCL, ganglion cell layer. Scale bars = 100 µM.
(Jacobson et al., 2007), which was noted as likely due to an
increase in gliosis within the tissue from acute cell death. We
may not see this effect in slower forms of retinal degeneration
such as RP simply because these conditions take many years
to progress in the human, giving time for the glial tissue
and photoreceptor debris to clear. Thus, a superficially thick
retinal profile may naturally result from any form of rapid
photoreceptor death and is not solely a feature of ATP induced
phototoxicity.
ATP Injection Causes Inner Retinal Neural
Remodeling and Widespread Müller Cell
Gliosis
A common feature of many photoreceptor degenerations is a
progressive and pathological remodeling of the neural retina
in response to a primary photoreceptor loss (Marc et al.,
2003; Jones et al., 2005). In this feline model of ATP-induced
retinal degeneration, we observed many markers of mid to
late-stage retinal remodeling present in both the INL and
GCLs of the inner retina. Specifically, there was patchy loss
of bipolar cells, gross displacement of INL neurons into the
outer and inner nuclear and synaptic layers, a generalized
loss of normal markers of synaptic function, evidence for
abnormal horizontal or amacrine cell neurite growth into the
outer retina and the presence of non-neural (gliotic) tissue
especially within the outer retina and GCLs. The severity of
inner retinal remodeling appeared to be relatively inconsistent
across the retina, with the most severe remodeling occurring
in regions devoid of even residual photoreceptor nuclei. This
is consistent with both human degenerations and animal
models of blindness that characteristically show non-uniform
cell survival and remodeling, with neural survival particularly
associated with the survival of cone photoreceptors (Jones
et al., 2003, 2005). The ganglion cell population was conserved
according to cell counts; however the worst affected areas
had an obvious visual reduction in the number of surviving
RGCs so we believe it likely that there is some reduction
that our low sample size could not detect statistically. Retinal
ganglion cell morphology is relatively well maintained in
inherited photoreceptor degenerations (Strettoi et al., 2002; Jones
et al., 2005; Mazzoni et al., 2008) although there are reports
of up to 70% RGC loss in the most severely degenerated
human cases (Santos et al., 1997). Some level of ganglion cell
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survival is vital for the success of several visual restoration
strategies including retinal prosthesis and photoreceptor sheet
transplants (Seiler and Aramant, 2012; Zrenner, 2013). Thus,
these findings help to validate the use of the ATP-injected
model of retinal degeneration to trial these types of restoration
strategies.
GFAP-positive Müller cell gliosis occurred as a result of ATP
injection, with a thick glial scar commonly observed across the
inner and outer retina, entombing the surviving neural tissue.
Müller cell gliosis was present in all areas of the retina but
appeared thickest in degenerating and degenerated regions. In
many areas, the lateral glial scar and/or vertical glial columns
formed by Müller cells appeared to completely displace the
surrounding neural tissue. Müller cell gliosis appeared to be
even more severe and disruptive in our specific model of
retinal degeneration in the feline compared to other models
(Jones et al., 2003, 2011; Vessey et al., 2014). Although it
is not clear why gliosis appears to be so prevalent in our
model we propose that this is likely a combination of direct
activation of glial cells in the retina by ATP injection (Köles
et al., 2011), the focal retinal detachments we observed in
these animals (Aplin et al., 2014) and the rapid rate of
primary photoreceptor degeneration leading to an activation
of the gliotic response. The observed increased microglia
activity suggested an ongoing inflammatory stimulus in these
animals.
Overall our results closely mimic a previous study which
characterized retinal remodeling events in ATP-injected rat
retinae (Vessey et al., 2014). Retinal remodeling is often
separated into three distinct stages. The initial evidence of
photoreceptor cell death is referred to as phase 1 retinal
remodeling; gross outer retina and subtle inner retinal changes
indicate phase 2 remodeling; and total loss of photoreceptors
and gross inner retinal changes define phase 3 remodeling
(Marc et al., 2003; Jones et al., 2005). Our data suggest
that at 12 weeks post ATP injection, the feline retina is
undergoing general phase 2 remodeling with localized phase
3 remodeling in areas with total photoreceptor loss, and
very occasional phase 1 remodeling occurring in areas with
greater than normal photoreceptor survival. Again, this time
course remains very similar to that reported previously in the
ATP-injected rat model of retinal degeneration (Vessey et al.,
2014).
The mechanism behind ATP mediated photoreceptor cell
death is still not completely understood. ATP-mediated cell
death is thought to play a role in inherited retinal degenerations
(Puthussery and Fletcher, 2009; Fletcher, 2010), and although
the process likely involves direct phototoxic activation of the
P2X7 purinergic receptor (Puthussery and Fletcher, 2004;
Puthussery et al., 2006; Vessey et al., 2012, 2014), purinergic
receptors are also found throughout the retina on neural,
glial and endothelial cells (Puthussery and Fletcher, 2004;
Puthussery et al., 2006; Mitchell and Reigada, 2008). Thus,
a secondary effect on photoreceptors or other neural cells
must also play some part in the disease phenotype observed
in the ATP injected feline and rodent retina. For example,
purinergic receptors are found on cells within the retinal
pigment epithelium (Tovell and Sanderson, 2008; Wan et al.,
2011), and death or dysfunction of RPE cells could also lead
to photoreceptor loss as is observed in other models of retinal
degeneration such as sodium iodate (NaIO3) phototoxicity
(Enzmann et al., 2006). Purinergic receptors are also found
on glial cells within the central nervous system (CNS) and
retina, and play a role in neural-glial cell signaling (Fields
and Burnstock, 2006; Newman, 2006). It is possible that
the increased gliotic activity observed in our model may be
in part a primary effect of high extracellular ATP rather
than a secondary response to photoreceptor degeneration.
An increased gliotic response could contribute to the acute
and ongoing loss of photoreceptors and potentially inner
retinal neurons in the ATP induced model of photoreceptor
degeneration (Bringmann et al., 2009). Further to this it
is possible that ATP has direct pathological interactions
with other cells types in the retina which were otherwise
not revealed from our analysis, especially as retinal
purines have not been fully characterized in the feline.
However, given how closely our findings resemble previous
descriptions of retinal remodeling including the ATP
injected and P23H rat, and the wide array of remodeling
markers identified in our tissue, we do not think our
data can be explained as a purely primary effect of ATP
phototoxicity.
The ATP injected model of retinal degeneration provides
a novel model of photoreceptor degeneration with unique set
of advantages and disadvantages compared to other transgenic
and toxic models of retinal degeneration in the feline and other
larger-eyed animal models. The ATP induced model of retinal
degeneration in the feline bypasses many of the limitations
of comparable transgenic models such as the Abyssinian cat
(Narfström and Nilsson, 1987; Kang Derwent et al., 2006)
or rhodopsin transgenic pig (Petters et al., 1997; Li et al.,
1998), as it is cheap, rapid, widely available and the injection
protocol is relatively simple to perform. However, ATP does
not closely mimic the initial disease etiology or rate of disease
progression in human RP, which typically occurs over a
period of many years. Fast-acting phototoxic compounds as
models of retinal degeneration are thus a compromise between
accessibility and the specificity of the model, and are more
suitable for therapeutic interventions that are in themselves
relatively generic such as visual prostheses or photoreceptor
transplants.
The ATP model of retinal degeneration also benefits
from being a unilateral model of retinal degeneration.
Other common toxic models of photoreceptor degeneration
such as N-methyl-N-nitrosourea (MNU), NaIO3 and
iodoacetic acid (IAA; Kiuchi et al., 2002; Noel et al.,
2012; Chen et al., 2014) have similar disease progression
timelines but must be applied systemically and cause
bilateral blindness. Although there have been some recent
progress in translating MNU into a unilateral model
(Rösch et al., 2014), the compound is highly carcinogenic
and the long term-effects of unilateral MNU injection still
remain uncharacterized. A unilateral model of blindness
is ideal as it allows for a fellow eye control. In a larger
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eyed model, unilateral blindness also reduces housing and
support costs for the animals and alleviates the ethical
concerns involved with bilateral blindness in a primarily
visual animal.
In conclusion, we assessed neural and glial morphology
using immunohistochemistry in feline retinae at 30 h and
12 weeks after unilateral intravitreal injection with ATP
as a toxic model of photoreceptor degenerations. There
was evidence of severe photoreceptor loss at 30 h and
progressive photoreceptor loss and outer retinal degeneration
12 weeks post ATP injection. Markers in inner retinal neurons
corresponding to phase 2 and phase 3 retinal remodeling were
present throughout ATP injected retinae. All retinal layers
showed evidence of disorganization and neural loss, although
ganglion cells remained relatively well conserved. Extensive and
severe Müller cell gliosis was observed throughout the retina,
particularly in areas with greater retinal degeneration. In the
worst affected areas, fibrotic tissue had completely displaced
the neural retina. Our data suggest that the ATP-induced
model of retinal degeneration in the feline follows a pattern
of secondary neural and glial change that closely mimics
remodeling a seen in other models of retinal degeneration.
This characterization should provide a valuable reference
tool for future studies using the ATP injected model of
photoreceptor degeneration to assess the viability of visual
restorative therapies.
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